Irritable Bowel Syndrome and Food Sensitivity

Completed · Not applicable

Conditions studied: Irritable Bowel Syndrome

In brief

The primary objective of the clinical trial portion of this study is to assess whether an individualized dietary plan based on a commercial food sensitivity assay provides specific benefit in a randomized controlled trial in adults with irritable bowel syndrome (IBS).

Key facts

Study ID

NCT02186743

Run by

Yale University

People needed

58

Starts

2014-07-01

Expected to finish

2016-01-01

Last updated by the study team

2017-10-18

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Between 18-70 years of age.
• Irritable Bowel Syndrome by Rome III criteria.
• Stable dose (30 days) of concurrent IBS medications
• Agree not to make significant changes to their diet during the study
• IBS-SSS score of >150

You may not qualify if…

• History of major abdominal surgeries
• History of inflammatory bowel disease
• Antibiotic use within 1 month of enrollment
• Radiation proctitis or other known poorly controlled medical conditions that could interfere with bowel function
• Current use of opioid pain medications (except for NSAIDs)
• Previous experience participating in dietary studies for IBS
• Current use of medications which are known to be affected by modest dietary changes
• Vitamin C use of >2000 mg/day
• Quercetin use of >500 mg/day

Where it is running

• Yale University — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.